ABI: mHealth Wearables Drive Disruption in Diabetic Care

Wearables Easy to Like, Hard to UseThis year, ABI Research announced Friday, the global diabetic population crossed half a billion, and it continues to grow.

In response, device manufacturers, healthcare providers, and patients are looking for ways to manage this long-term chronic disease in an efficient and unobtrusive way.

According to its latest research and projections, ABI indicates that wearable continuous glucose monitoring devices are “paramount.”

“Between now and 2021, more than nine million wearable CGM devices will ship, as they increasingly gain support and challenge finger prick glucose meters,” the ABI report reads.

“mHealth wearable device manufacturers integrated the new, non-invasive CGMs and insulin pumps with cloud services, analytics tools, and predictive software to provide new types of pattern analysis in near real time,” says Ryan Harbison, Research Analyst at ABI Research.

This post was written by:

- who has written 2292 posts on mHealthWatch.

Contact the author